179 related articles for article (PubMed ID: 17063264)
1. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
2. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
4. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Tołoczko-Grabarek A; Gilbert M; Edler L; Zapatka M; Eils R; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2010 Jan; 119(1):201-11. PubMed ID: 19360465
[TBL] [Abstract][Full Text] [Related]
6. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
7. [MTHFR polymorphisms, dietary folate intake and risks to breast cancer].
Gao CM; Kazuo T; Tang JH; Cao HX; Ding JH; Wu JZ; Wang J; Liu YT; Li SP; Su P; Keitaro M; Toshiro T
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):576-80. PubMed ID: 19954067
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
9. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
10. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
[TBL] [Abstract][Full Text] [Related]
11. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
12. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.
Grieu F; Powell B; Beilby J; Iacopetta B
Anticancer Res; 2004; 24(5B):3215-9. PubMed ID: 15510613
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
16. Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubinski J; Scott RJ; Hamann U
J Med Genet; 2007 Jun; 44(6):408-11. PubMed ID: 17220212
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
18. [Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer].
Zhang XM; Miao XP; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):700-3. PubMed ID: 16447641
[TBL] [Abstract][Full Text] [Related]
19. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
